Nancy Miller-Rich

Nancy is a biotech executive with over 35 years in global commercial, BD experience and strategy. She currently holds board positions at Intercept Pharmaceutical, Kadmon, and Alderya Therapeutics, and TB Alliance. She is also an advisor to several biotech startups, including Ten63.

Formerly, Nancy was Senior Vice President, Head of BD and Strategy the Human Health Division for Merck & Co. and held executive roles Schering Plough and Sandoz.